Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SHIP1 activators(Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Preclinical | CZ | 01 Oct 2020 |